Abstract: A data management system that enables appropriate management of data in offices is provided. A data management system including one or more server devices provided in each of a plurality of offices, in which: when receiving a request for data of another office from a client terminal, a setting unit sets information indicating acquisition of data of the other office in setting information; and an acquisition unit acquires the data of the other office from the server device in the other office according to the setting information in which a change is detected by a monitoring unit.

Abstract: The object of the invention is to provide a method for easily and objectively detecting mood disorders in a subject by measuring the expression levels of prescribed genes in the peripheral blood of the subject, the reliability of the detection result being high. The invention also provides a method for detecting mood disorders in a subject, the method having a step for measuring the gene expression levels of ribosomal protein genes, CDKN1C, or any combination thereof in the peripheral blood derived from the subject, and detecting whether or not the subject has mood disorders on the basis of the measurement results.

Abstract: The object of the invention is to provide a method for counting the number of nucleic acid molecules in a mixture of a plurality of nucleic acid molecules more highly accurately.

Abstract: [Problem to be Solved by the Invention] To predict the efficacy of a rheumatoid arthritis therapeutic agent, or find a simple and highly reproducible hiomarker that can be used to assess the activity of disease conditions and states of rheumatoid arthritis, and provide an effective method. [Solution] A method for predicting the efficacy of a rheumatoid arthritis therapeutic agent on a.

Abstract: The object of the invention is to provide a method for counting the number of nucleic acid molecules in a mixture of a plurality of nucleic acid molecules more highly accurately.

Abstract: The object of the invention is to provide a method for counting the number of nucleic acid molecules in a mixture of a plurality of nucleic acid molecules more highly accurately.

Abstract: The object of the invention is to provide a method for easily and objectively detecting mood disorders in a subject by measuring the expression levels of prescribed genes in the peripheral blood of the subject, the reliability of the detection result being high. The invention also provides a method for detecting mood disorders in a subject, the method having a step for measuring the gene expression levels of ribosomal protein genes, CDKN1C, or any combination thereof in the peripheral blood derived from the subject, and detecting whether or not the subject has mood disorders on the basis of the measurement results.

Abstract: The object of the invention is to provide a method for counting the number of nucleic acid molecules in a mixture of a plurality of nucleic acid molecules more highly accurately.

Abstract: A coaxial connector is manufactured to have a structure in which a first resin member is not easily separated from an external terminal. A coaxial connector according to the present disclosure includes a first resin member, a second resin member attached to the first resin member, a fixed terminal and a movable terminal disposed between the first resin member and the second resin member, and an external terminal attached to outer peripheries of the first resin member and the second resin member. The external terminal includes a cylindrical accommodating portion that accommodates the first resin member, and the first resin member includes a resin engagement portion. The resin engagement portion is engaged with the accommodating portion, so that separation of the first resin member is prevented.

Abstract: A serum resistin level reducing agent that comprises a cell wall disrupted product of a Chlorella pyrenoidos, and that reduces a serum resistin level, as an agent for oral administration. A food or beverage composition for reducing a serum resistin level that comprises a cell wall disrupted product of a Chlorella pyrenoidos, and that reduces a serum resistin level. A method of reducing a serum resistin level by applying a cell wall disrupted product of a chlorella for oral administration. A use of a cell wall disrupted product of a chlorella for oral administration for reducing a serum resistin level.

Abstract: A coaxial connector is manufactured to have a structure in which a first resin member is not easily separated from an external terminal. A coaxial connector according to the present disclosure includes a first resin member, a second resin member attached to the first resin member, a fixed terminal and a movable terminal disposed between the first resin member and the second resin member, and an external terminal attached to outer peripheries of the first resin member and the second resin member. The external terminal includes a cylindrical accommodating portion that accommodates the first resin member, and the first resin member includes a resin engagement portion. The resin engagement portion is engaged with the accommodating portion, so that separation of the first resin member is prevented.

Abstract: A serum resistin level reducing agent that comprises a cell wall disrupted product of a Chlorella pyrenoidos, and that reduces a serum resistin level, as an agent for oral administration. A food or beverage composition for reducing a serum resistin level that comprises a cell wall disrupted product of a Chlorella pyrenoidos, and that reduces a serum resistin level. A method of reducing a serum resistin level by applying a cell wall disrupted product of a chlorella for oral administration. A use of a cell wall disrupted product of a chlorella for oral administration for reducing a serum resistin level.

Abstract: Described herein is a receptacle for coaxial connector whose outer shape is made small and short in height while ensuring reliability. The receptacle for coaxial connector includes an outer conductor having a tubular portion, a central conductor having a contact portion extending in an axis direction in an internal space of the tubular portion, and an insulator holding the outer conductor and the central conductor in an insulating state. A region of the central conductor other than a central-conductor drawing portion thereof has outwardly projected portions in planar view of the central conductor.

Abstract: Described herein is a receptacle for coaxial connector whose outer shape is made small and short in height while ensuring reliability. The receptacle for coaxial connector includes an outer conductor having a tubular portion, a central conductor having a contact portion extending in an axis direction in an internal space of the tubular portion, and an insulator holding the outer conductor and the central conductor in an insulating state. A region of the central conductor other than a central-conductor drawing portion thereof has outwardly projected portions in planar view of the central conductor.

Abstract: The invention relates to a cancer predicting method and a drug design method. Specifically, the invention relates to a method for predicting cancer which is useful for the genetic diagnosis for evaluating the malignancy of cancer. The invention also relates to a method for designing a drug based on the result of the above prediction method.